← FDA ENFORCEMENT
D-0258-2026Class II

Advanced Pharmaceutical Technology, Inc.

What this record is not

A recall record is reproduced as FDA published it, and the classification is FDA’s. SPEQ adds no interpretation, and a recall concerns the products and dates in the record — it is not a statement about a company’s other products or its current status.

Recalling firm
Advanced Pharmaceutical Technology, Inc.
Product type
Drug
Status
Ongoing
Report date
2026-01-21
Distribution
GA, NY, TX, Puerto Rico, United Kingdom, Malta, Greece
Firm state
NY
Product quantity
22,843 pellets
Initiated by
Voluntary: Firm initiated
SPEQ quality domain
Environmental Monitoring
Reason for recall

Lack of Assurance of Sterility: Potential microbial contamination of subcutaneous pellets.

Product description

TESTO-100 CIII (testosterone 100 mg), 10 Sterile Pellets per carton, Rx only, Manufactured by: Advanced Pharmaceutical Technology, 132 South Central Avenue, Elmsford, NY 10523, NDC# 57377-100-01

Code / lot info

Lot #: P-22-3, Exp 06-2027

Data: U.S. FDA. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification. Open the enforcement explorer →